0.346
                                            
                                Panoramica
                                Notizia
                                Cronologia dei prezzi
                                Financials
                                    Perché ADIL Giù?
                                Forum
                                Previsione
                                    Frazionamento azionario
                        
                        Precedente Chiudi:
              $0.345
            Aprire:
              $0.331
            Volume 24 ore:
                64,925
            Relative Volume:
              0.10
            Capitalizzazione di mercato:
                $7.53M
            Reddito:
              -
            Utile/perdita netta:
              $-6.07M
            Rapporto P/E:
              -0.0599
            EPS:
                -5.78
            Flusso di cassa netto:
                $-7.34M
            1 W Prestazione:
              -8.13%
            1M Prestazione:
              -12.98%
            6M Prestazione:
                -48.25%
            1 anno Prestazione:
              -65.50%
            Adial Pharmaceuticals Inc Stock (ADIL) Company Profile
Nome
                  
                      Adial Pharmaceuticals Inc
                    
                Settore
                  Industria
                  Telefono
                  
                      434-422-9800
                    
                Indirizzo
                  
                      1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
                    
                Confronta ADIL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                ADIL
                            
                             
                        Adial Pharmaceuticals Inc 
                           | 
                    0.345 | 7.53M | 0 | -6.07M | -7.34M | -5.78 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    418.64 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    640.76 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    426.54 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    837.32 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.10 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione | 
|---|---|---|---|
| 2024-11-14 | Iniziato | Rodman & Renshaw | Buy | 
| 2018-10-30 | Iniziato | Maxim Group | Buy | 
| 2018-10-11 | Iniziato | Dawson James | Buy | 
Adial Pharmaceuticals Inc Borsa (ADIL) Ultime notizie
Should I hold or sell Adial Pharmaceuticals Inc. stock in 2025July 2025 PostEarnings & High Return Trade Opportunity Guides - newser.com
Real time social sentiment graph for Adial Pharmaceuticals Inc.Watch List & Trade Opportunity Analysis Reports - newser.com
Will Adial Pharmaceuticals Inc. stock continue upward momentum2025 Geopolitical Influence & High Accuracy Investment Signals - newser.com
Will Adial Pharmaceuticals Inc. stock benefit from infrastructure spendingMarket Trend Summary & Free Expert Approved Momentum Trade Ideas - newser.com
What high frequency data says about Adial Pharmaceuticals Inc.July 2025 PostEarnings & Stepwise Entry and Exit Trade Signals - newser.com
Heatmap analysis for Adial Pharmaceuticals Inc. and competitorsWeekly Trade Recap & Weekly Hot Stock Watchlists - newser.com
Why analysts upgrade Adial Pharmaceuticals Inc. stockJuly 2025 Sector Moves & Breakout Confirmation Trade Signals - newser.com
Has Adial Pharmaceuticals Inc. formed a bullish divergenceTrade Analysis Report & Low Drawdown Investment Strategies - newser.com
Forecasting Adial Pharmaceuticals Inc. price range with options dataEarnings Recap Report & AI Driven Stock Reports - newser.com
Is this a good reentry point in Adial Pharmaceuticals Inc.Market Risk Summary & Daily Entry Point Trade Alerts - newser.com
How hedge fund analytics apply to Adial Pharmaceuticals Inc. stockQuarterly Profit Summary & Safe Capital Growth Stock Tips - newser.com
Adial Pharmaceuticals, Inc. (ADIL) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Can Adial Pharmaceuticals Inc. stock withstand economic slowdownWeekly Market Outlook & Intraday High Probability Setup Alerts - newser.com
Detecting price anomalies in Adial Pharmaceuticals Inc. with AIWeekly Market Outlook & Weekly Chart Analysis and Trade Guides - newser.com
Full technical analysis of Adial Pharmaceuticals Inc. stockRisk Management & Weekly Top Performers Watchlists - newser.com
Adial Pharmaceuticals Inc Stock Analysis and ForecastAnalyst Downgrades & Small Budget Capital Gains - earlytimes.in
Adial Pharmaceuticals Inc Azioni (ADIL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
        Apri su Yahoo
        |
        Apri su Google
            |
            Aperto in Finviz
        |
        Apri in MarketWatch
            |
            Aperto a EDGAR    
        |
        Aperto su Reuters
    
    
                Capitalizzazione:
                 
                  | 
                Volume (24 ore):